Utama › Purpura Trombositopenik Idiopatik › New Jersey
Kajian klinikal Purpura Trombositopenik Idiopatik di New Jersey
4 kajian untuk Purpura Trombositopenik Idiopatik sedang mencari peserta di lokasi di New Jersey.
Teks kajian rasmi (Bahasa Inggeris)
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Astera Cancer Center, East Brunswick
- Summit Medical Group, Summit
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07421167A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment
- Novartis, East Hanover
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07786077A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- American Oncology Partners of Maryland, PA, Morristown
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06948318A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Regional Cancer Care Associates, LLC (RCCA), Little Silver
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Mei 2026 · NCT06544499Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.